
InnaMed
InnaMed is a YC Winter 2017 (W17) company. Based in Philadelphia, PA, USA. Team of 7.
About InnaMed
Summary
InnaMed builds an at-home blood testing device and software platform, called HomeLab, that lets patients collect and analyze blood samples without visiting a clinic. Physicians and researchers receive structured clinical reports delivered directly into their EMR, LIMS, or EDC systems, replacing the lab-referral workflow. Trend and pattern-matching software then supports prescription and dosing decisions, connecting the at-home data to telehealth care.
Go-to-market
Healthcare providers and clinical researchers are the primary buyers, receiving reports through integrations with existing health record and data-capture systems; patients access the service from home, removing the need for in-person lab visits.
From the Y Combinator listing
At-home blood testing: measure + analyze + enhance.
InnaMed's HomeLab device and software take the hassle out of blood testing and let you access precision medical care from the comfort and privacy of your home. Healthcare providers and researchers can now receive timely clinical reports that they are accustomed to interpreting directly to their EMR, LIMS or EDC system. Trend identification and pattern matching software can guide decision making in the prescription and dosing of therapy and deep integration with the healthcare system and telehealth services allows for data driven care while also ensuring human connection.
Facts
- Healthcare / Healthcare -> Diagnostics
- Philadelphia, PA, USA
- 7
- Inactive
- Early
Founders (1)
- Anup Singh
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works